Johnson & Johnson and Bayer’s Xarelto, once king of the warfarin alternative market, is now chasing chasing Pfizer and Bristol-Myers Squibb’s Eliquis. But with a new approved indication in the books—its eighth—it’s not backing down. The FDA on Monday approved Xarelto to help prevent blood clots for acutely ill patients without a high risk of bleeding during… Read More »
For women having breast cancer in the process of radiation therapy, yoga provides unique benefits other than reducing fatigue. Researchers revealed that although fatigue had been counteracted with basic stretching exercises, individuals who took part in yoga exercises in which controlled meditation, breathing, as well as relaxation techniques were integrated into their treatment plan had… Read More »
At 30, Amanda Johnson learned that she had about 16 months to live after her on-again-off-again headaches lead to a glioblastoma diagnosis. In fact, the tumor in her brain was so large that it was threatening even the short time frame that she was given. Amanda Johnson, pictured with dad Larry, started getting headaches, which… Read More »
In another big move aimed at its healthcare clients, Amazon Web Services revealed this week that its Textract machine learning technology – which can help healthcare organizations more easily extract data from scanned documents – is now HIPAA eligible, joining a half-dozen other cloud-based AI tools. WHY IT MATTERSIt’s important to note that HIPAA-eligible is… Read More »